| 151 |
32984521 | AUTOIMMUNE DIABETES IN A PATIENT WITH HUMAN IMMUNODEFICIENCY VIRUS ON ANTI-RETROVIRAL THERAPY WITH LITERATURE REVIEW. | 2020 Sep-Oct |
1 |
| 152 |
33030354 | Treatment satisfaction, safety, and effectiveness of biosimilar insulin glargine is comparable in patients with type 2 diabetes mellitus after switching from insulin glargine or insulin degludec: a post-marketing safety study. | 2020 Dec |
4 |
| 153 |
33035599 | Liraglutide or insulin glargine treatments improves hepatic fat in obese patients with type 2 diabetes and nonalcoholic fatty liver disease in twenty-six weeks: A randomized placebo-controlled trial. | 2020 Dec |
5 |
| 154 |
33133703 | Critical Low Catastrophe: A Case Report of Treatment-Refractory Hypoglycemia following Overdose of Long-Acting Insulin. | 2020 |
1 |
| 155 |
33166419 | (Ultra-)long-acting insulin analogues versus NPH insulin (human isophane insulin) for adults with type 2 diabetes mellitus. | 2020 Nov 9 |
3 |
| 156 |
33247658 | Gla-100 Development: a Story of 'Serendipitous' Disruptive Innovation. | 2020 Dec |
5 |
| 157 |
33247659 | Two Decades of Gla-100-Reflections from the Pivotal Clinical Trials. | 2020 Dec |
1 |
| 158 |
33247660 | Adoption of Gla-100 in India and its Impact on Insulin Usage Patterns. | 2020 Dec |
1 |
| 159 |
33247661 | Gla-100 Initiation: The When, Why, and How. | 2020 Dec |
1 |
| 160 |
33247662 | Basal Insulin Titration: Moving Towards a More Patient-Centric Approach with Gla-100 in India. | 2020 Dec |
1 |
| 161 |
33247666 | Use of Gla-100 in Special Situations. | 2020 Dec |
1 |
| 162 |
33299890 | Effect of Dapagliflozin on Glycemic Variability in Patients with Type 2 Diabetes under Insulin Glargine Combined with Other Oral Hypoglycemic Drugs. | 2020 |
2 |
| 163 |
29861115 | [Effectiveness of an intervention strategy in the biosimilar glargine prescription pattern in primary care]. | 2019 Jun - Jul |
1 |
| 164 |
29947060 | Efficacy and safety of insulin glargine 300 U/mL vs insulin degludec in patients with type 2 diabetes: A randomized, open-label, cross-over study using continuous glucose monitoring profiles. | 2019 Mar |
1 |
| 165 |
29987755 | Adjustment of insulin doses when switching from glargine 100 U/ml or detemir to degludec: an observational study. | 2019 Mar |
5 |
| 166 |
29989335 | Comparison of insulin glargine 300 U/mL and insulin degludec using flash glucose monitoring: A randomized cross-over study. | 2019 Mar |
1 |
| 167 |
30036160 | Effect of Telephone-Delivered Interventions on Glycemic Control in Type 2 Diabetes Treated with Glargine Insulin. | 2019 Jun |
6 |
| 168 |
30112792 | Efficacy and safety of MYL-1501D versus insulin glargine in patients with type 2 diabetes after 24 weeks: Results of the phase III INSTRIDE 2 study. | 2019 Jan |
1 |
| 169 |
30122087 | Formulary Considerations for Insulins Approved Through the 505(b)(2) "Follow-on" Pathway. | 2019 Feb |
1 |
| 170 |
30160324 | Differences in UK healthcare professionals' knowledge, attitude and practice towards infliximab and insulin glargine biosimilars. | 2019 Apr |
2 |
| 171 |
30270723 | Combined Insulin and GLP-1 Receptor Agonists: Simplifying Treatment or Adding Obstacles? | 2019 Aug |
1 |
| 172 |
30328252 | GlucoTab-guided insulin therapy using insulin glargine U300 enables glycaemic control with low risk of hypoglycaemia in hospitalized patients with type 2 diabetes. | 2019 Mar |
2 |
| 173 |
30341767 | Liraglutide, Sitagliptin, and Insulin Glargine Added to Metformin: The Effect on Body Weight and Intrahepatic Lipid in Patients With Type 2 Diabetes Mellitus and Nonalcoholic Fatty Liver Disease. | 2019 Jun |
2 |
| 174 |
30369394 | Insulin depot absorption modeling and pharmacokinetic simulation with insulin glargine 300 U/mL
. | 2019 Jan |
6 |
| 175 |
30370783 | Rationale for a titratable fixed-ratio co-formulation of a basal insulin analog and a glucagon-like peptide 1 receptor agonist in patients with type 2 diabetes. | 2019 May |
1 |
| 176 |
30393950 | Double-blind, randomized clinical trial comparing the efficacy and safety of continuing or discontinuing the dipeptidyl peptidase-4 inhibitor sitagliptin when initiating insulin glargine therapy in patients with type 2 diabetes: The CompoSIT-I Study. | 2019 Apr |
1 |
| 177 |
30421545 | Insulin glargine/lixisenatide fixed-ratio combination improves glycaemic variability and control without increasing hypoglycaemia. | 2019 Mar |
1 |
| 178 |
30443804 | Successful Outcomes with Insulin Degludec in Pregnancy: A Case Series. | 2019 Feb |
1 |
| 179 |
30520252 | Predictive factors associated with three years of response to HbA1c goals with exenatide QW or insulin glargine: Post-hoc analysis of the DURATION-3 study. | 2019 Apr |
2 |
| 180 |
30520564 | Basal insulin therapy: Unmet medical needs in Asia and the new insulin glargine in diabetes treatment. | 2019 May |
2 |
| 181 |
30539523 | A Review of the Safety and Adverse Event Profile of the Fixed-Ratio Combination of Insulin Glargine and Lixisenatide. | 2019 Feb |
1 |
| 182 |
30604091 | Lilly Insulin Glargine Versus Lantus® in Insulin-Naïve and Insulin-Treated Adults with Type 2 Diabetes: A Randomized, Controlled Trial (ELEMENT 5). | 2019 Feb |
1 |
| 183 |
30619716 | Twice-daily insulin glargine for patients with uncontrolled type 2 diabetes mellitus. | 2019 Mar |
1 |
| 184 |
30623349 | Achieving Glycaemic Control with Concentrated Insulin in Patients with Type 2 Diabetes. | 2019 Feb |
3 |
| 185 |
30641166 | An observational, multicentre study on different insulin glargine U100 titration algorithms used in patients with type 2 diabetes in daily medical practice in Adriatic countries: The ADRESA study. | 2019 Apr |
2 |
| 186 |
30641690 | Impact of Ramadan Focused Education Program on medications adjustment for patients with type 2 diabetes in a primary health care institution in Saudi Arabia. | 2019 Jan - Feb |
1 |
| 187 |
30653163 | Marfan syndrome with type 2 diabetes mellitus: A case report from China. | 2019 Jan |
1 |
| 188 |
30693980 | Glycemic Control in Adult Surgical Patients Receiving Regular Insulin Added to Parenteral Nutrition vs Insulin Glargine: A Retrospective Chart Review. | 2019 Oct |
2 |
| 189 |
30724009 | When basal insulin is not enough: A dose-response relationship between insulin glargine 100 units/mL and glycaemic control. | 2019 Jun |
1 |
| 190 |
30729549 | Reply. | 2019 May |
1 |
| 191 |
30735983 | Incorporating Long-Acting Insulin Glargine Into the UVA/Padova Type 1 Diabetes Simulator for In Silico Testing of MDI Therapies. | 2019 Oct |
3 |
| 192 |
30762290 | Body weight and eGFR during dulaglutide treatment in type 2 diabetes and moderate-to-severe chronic kidney disease (AWARD-7). | 2019 Jun |
1 |
| 193 |
30785660 | Effects of basal insulin glargine and omega-3 on lower limb arterial disease outcome in patients with dysglycaemia: An analysis of the Outcome Reduction with an Initial Glargine INtervention (ORIGIN) trial. | 2019 Jun |
1 |
| 194 |
30789066 | Premix insulins in type 1 diabetes: the coming of degludec/aspart. | 2019 Apr |
2 |
| 195 |
30793566 | [Basal insulin glargine-lixisenatide fixed ratio combination (Suliqua®)]. | 2019 Feb |
3 |
| 196 |
30828929 | Better glycaemic control with BioChaperone glargine lispro co-formulation than with insulin lispro Mix25 or separate glargine and lispro administrations after a test meal in people with type 2 diabetes. | 2019 Jul |
2 |
| 197 |
30850995 | Cardiovascular safety and lower severe hypoglycaemia of insulin degludec versus insulin glargine U100 in patients with type 2 diabetes aged 65 years or older: Results from DEVOTE (DEVOTE 7). | 2019 Jul |
1 |
| 198 |
30900200 | A Propensity Score Matched Comparison of Brand and Biosimilar Basal Insulin in Non-Critical Hospitalized Patients with Type 2 Diabetes Mellitus. | 2019 May |
3 |
| 199 |
30929185 | Differentiating Basal Insulin Preparations: Understanding How They Work Explains Why They Are Different. | 2019 May |
12 |
| 200 |
30993855 | Efficacy and safety of a morning injection of insulin glargine 300 units/mL versus insulin glargine 100 units/mL in adult patients with type 1 diabetes: A multicentre, randomized controlled trial using continuous glucose monitoring. | 2019 Aug |
1 |